Ischemic Renal Disease: Impact of cardiovascular risk factors and smoking

Contributions to Nephrology

Volumn 130, Issue , 2000, Pages 68-74

  Baggio, Bruno ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASE; HUMAN; ISCHEMIA; KIDNEY; KIDNEY ARTERY STENOSIS; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SMOKING; VASCULARIZATION;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; HUMANS; ISCHEMIA; KIDNEY; RENAL ARTERY OBSTRUCTION; RISK FACTORS; SMOKING;

EID: 0033643051     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060043     Document Type: Article

References (24)

1. Zucchelli P, Zuccalà A: Ischemic nephropathy in the elderly. Contrib Nephrol. Basel, Karger, vol 105, pp 13-24.
2. Metcalfe W, Reid AW, Geddes CC: Prevalence of angiographic atherosclerotic renal artery disease and its relationship to the anatomical extent of peripheral vascular atherosclerosis. Nephrol Dial Transplant 1999 14:105-108.
3. Hansen KP: Prevalence of ischaemic nephropathy in the atherosclerotic population. Am J Kidney Dis 1994;24:615-621.
4. Missouris CG, Papavassiliou MB, Khaw K, Hall T, Belli AM, Buckenham T, MacGregor GA: High prevalence of carotid artery disease in patients with atheromatous renal artery stenosis. Nephrol Dial Transplant 1998;13:945-948.
5. Greco BA, Breyer JA: Atherosclerotic ischaemic renal disease. Am J Kidney Dis 1997;29:167-187.
6. Jacobson HR: Ischemic renal disease: An overlooked clinical entity? Kidney Int 1988;34:729-743.
7. Budakovic A, Gambaro G, Del Prete D, Verlato F, Casara D, Saladini G, Baggio B: Renal function in subjects with peripheral atherosclerosis. Nephrol Dial Transplant 1998;13:6,A136.
8. Gambaro G, Verlato F, Budakovic A, Casara D, Saladini G, Del Prete D, Bertaglia G, Masiero M, Checchetto S, Baggio B: Renal impairment in chronic cigarette smokers. J Am Soc Nephrol 1998;9:562-567.
9. Muhlauser I: Cigarette smoking and diabetes: An update. Diabet Med 1994;11:336-341.
10. Chapman AB, Johnson AM, Gabow PA, Schrier RW: Overt proteinuria and microalbuminuria in autosomal dominant polycistic kidney disease. J Am Soc Nephrol 1994;5:1349-1354.
11. Orth SR, Stockmann A, Conradt C, Ritz E, Ferro E, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schafer K, Sieberth HG, Wanner C, Watsschinger B, Zucchelli P: Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998;54:926-931.
12. Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler R, Panarelli W, De Santo NO: Microalbuminuria in nondiabetic adults: Relation of blood pressure, body mass index, plasma cholesterol levels, and smoking. The Gubbio population study. Arch Intern Med 1998;158:1933-1939.
13. Culleton BG, Larson MG, Evans JC, Wilson WF, Barret BJ, Parfrey PS, Levy D: Prevalence and correlates of elevated serum creatinine levels. Arch Intern Med 1999;159:1785-1790.
14. Cosio FG, Falkenhain MF, Pesavento TE, Yim S, Alamir A, Henry ML, Ferguson RM: Patient survival after renal transplantation. II. The impact of smoking. Clin Transplant 1999;13:336-341.
15. Baggio B, Budakovic A, Gambaro G: Cardiovascular risk factors, smoking and kidney function. Nephrol Dial Transplant 1998;S13:2-5.
16. Gambaro G, Brunello A, Vincenti M, Nassuato MA, Betaglia G, Baggio B: Renal tubular function in the elderly. Contrib Nephrol. Basel, Karger, 1993, vol 105, pp 81-84.
17. Sames K: The role of proteoglycans and glycosaminoglycans in aging. Interdisc Top Gerontol. Basel, Karger, 1994, vol 28.
18. Haremberg J, Malsch R, Piazolo L, Huhle G, Heene DL: Binding of glycosaminoglycans to leukocytes using fluorescent labeled GAG-derivates; in Haremberg J, Casu B (eds): Nonanticoagulant Actions of Glycosaminoglycans. New York, Plenum Press, 1966, pp 113-126.
19. Rusnati M, Coltrini D, Oreste P, Zoppetti G, Presta M: The interaction of basic fibroblastic growth factor with heparan sulfate proteoglycans: Biochemical and biological implications; in Haremberg J, Casu B (eds): Nonanticoagulant Actions of Glycosaminoglycans. New York, Plenum Press, 1966, pp 171-188.
20. Gambaro G, Baggio B: Role of glycosaminoglycans in diabetic nephropathy. Acta Diabetol 1992;89:149-155.
21. Tracy RE, Strong JP, Newman WP III, Malcom GT, Oalmann MC, Guzman MA: Renovasculopathies of nephrosclerosis in relation to atherosclerosis at ages 25 to 54 years. Kidney Int 1996;49:564-570.
22. Diamond JR: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 1991;S31:S29-S34.
23. Baylis C, Schmidt R: The aging glomerulus. Semin Nephrol 1996;16:265-276.
24. Sahai A, Mei C, Schrier RV, Tannen R: Mechanisms of chronic hypoxia-induced renal cell growth. Kidney Int 1999;56:1277-1281.